Tag:
Adasuve
Latest Headlines
Latest Headlines
FDA whacks Alexza Pharma with CRL for Adasuve
The FDA shot down the company's latest application because of manufacturing deficiencies related to the device used to take the inhaled antipsychotic drug, the company revealed last night.
Alexza's vaporized anti-psychotic threatened by dwindling cash
Even with a beefed up international commercial partnership, a public offering, restructuring and layoffs, Alexza Pharmaceuticals ($ALXA) has disclosed that its cash could run out by year-end.
Alexza's Adasuve slapped with delayed FDA review
The FDA slammed Alexza Pharmaceuticals ( $ALXA ) with another setback this week in its drive to bring the antipsychotic drug Adasuve to market. Regulators are extending by three months their review of
Alexza layoffs looming
Alexza Pharmaceuticals may be literally going for broke as it pursues approval of its inhaled fast-acting antipsychotic drug Adasuve. The company ($ALXA) announced that it will pursue significant,
Alexza readies "significant" layoffs, brings in Lazard to review asset sale
Just days after eking out an FDA expert panel vote in favor of its inhaled antipsychotic Adasuve, Alexza Pharma ( $ALXA ) has brought in Lazard to investigate the possible sale of assets as it prepares
Alexza shares spike after antipsychotic wins weak embrace from FDA panel
Alexza Pharma ( $ALXA ) just barely managed to clear one of the big hurdles that threatened to once again block its marathon effort at winning an FDA approval of the inhaled antipsychotic treatment
Alexza Pharma shares tank on FDA's safety concerns about Adasuve
Investors appeared to get worried after FDA staffers cited worries about lung safety issues with Alexza Pharmaceuticals' ( $ALXA ) inhaled anti-agitation drug Adasuve. Shares of the developers stock
